Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection
Article first published online: 20 MAY 2005
Volume 25, Issue 3, pages 571–579, June 2005
How to Cite
Zhang, H.-Y., Nanji, A. A., Luk, J. M., Huang, X.-R., Lo, C.-M., Chen, Y. X., Yuen, S.-T., Lan, H. Y. and Lau, G. K. K. (2005), Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection. Liver International, 25: 571–579. doi: 10.1111/j.1478-3231.2005.01047.x
- Issue published online: 20 MAY 2005
- Article first published online: 20 MAY 2005
- Received 7 May 2004, accepted 18 August 2004
- hepatic injury;
Background: Macrophage migration inhibitory factor (MIF) has emerged to be a pivotal cytokine in immune-mediated diseases.
Patients and methods: To investigate the role of MIF in chronic hepatitis B infection, we studied two groups of hepatitis B surface antigen positive patients: group 1 (immune tolerant, n=16) and group 2 (immune clearance, n=16). Serum level of MIF was measured by enzyme-linked immunosorbent assay and intrahepatic expression of MIF, macrophage and T-cell localisation were detected by double immunohistochemistry.
Results: An increased serum MIF correlated significantly with increased serum alanine aminotransferase activity (r=0.73, P<0.001) and the severity of necroinflammatory injury (r=0.642, P<0.001). In group 2, there was marked MIF mRNA expression in all KP-1+ macrophages and CD45RO+ activated T cells and, to a lesser extent, in hepatocytes within inflammatory areas. In contrast to its mRNA expression, the cytoplasmic MIF protein level in hepatocytes, infiltrating macrophages and T cells within the inflammatory area was reduced, which probably contributed to the increased serum MIF level.
Conclusions: Our data suggested that MIF played a role in sustaining cell-mediated hepatic injury during the immune-clearance phase of chronic hepatitis B infection.